Ghent, Belgium

Huybrecht T'Jollyn

This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huybrecht T'Jollyn. Retrieved from https://idiyas.com/inventor/huybrecht-t-jollyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Huybrecht T'Jollyn: Innovator in Pharmaceutical Formulations

Introduction

Huybrecht T'Jollyn is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. With a total of 3 patents to his name, T'Jollyn's work has had a meaningful impact on patient treatment options.

Latest Patents

Among his latest patents is a method of treating patients with long-acting injectable paliperidone palmitate formulations. This innovative approach aims to improve dosing regimens associated with extended-release paliperidone injectable formulations. His work in this area demonstrates a commitment to enhancing therapeutic outcomes for patients requiring such treatments.

Career Highlights

Huybrecht T'Jollyn is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at Janssen has allowed him to focus on developing advanced medication delivery systems that benefit patients worldwide. His expertise in this field has positioned him as a key player in pharmaceutical innovation.

Collaborations

Throughout his career, T'Jollyn has collaborated with esteemed colleagues such as Srihari Gopal and Raja Venkatasubramanian. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Huybrecht T'Jollyn's contributions to the field of pharmaceuticals, particularly in injectable formulations, highlight his innovative spirit and dedication to improving patient care. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…